α-Galactosidase A deficient mice: A model of Fabry disease
Toshio Ohshima(Waseda University), Ashok B. Kulkarni(National Institutes of Health), Michael M. Gottesman(National Cancer Institute), Ira Pastan(National Institutes of Health), Glenn Longenecker(National Institutes of Health), Gary J. Murray(National Cancer Institute), Yoshikazu Sugimoto(National Institute of Advanced Industrial Science and Technology), Jane M. Quirk(National Cancer Institute), William D. Swaim(National Institutes of Health), Roscoe O. Brady(Hadassah Medical Center), Carol Cardarelli(National Cancer Institute)
Cited by 370
Related Papers
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
|Pharmacological Reviews|2012|968
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
|Proceedings of the National Academy of Sciences|1996|900